Article
Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program.
The journal of prevention of Alzheimer's disease - 1 Jan 2023
Walsh T, Duff L, Riviere M-E, Tariot P N, Doak K, Smith M, Borowsky B, Lopez Lopez C, Arratia P C, Liu F, Scholten I, Gordon D, Arbuckle J, Graf A, Quinn M, Ricart J, Langbaum J B
Abstract excerpt
BACKGROUND: Alzheimer's disease (AD) prevention trials require a large outreach and screening funnel to identify cognitively unimpaired adults who meet the study's inclusion criteria, such as certain clinical or demographic criteria, genetic risk factors, and/or biomarker evidence of the disease. OBJECTIVES: Describe tactics and strategies to identify and enroll cognitively unimpaired adults with one...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.